{
    "eid": "2-s2.0-85105520120",
    "title": "Factors associated with recurrent postinfarction ventricular tachycardia following ablation",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Ablation techniques",
        "Coronary artery disease",
        "Key word: Tachycardia, ventricular",
        "Myocardial ischemia"
    ],
    "authors": [
        "Jakrin KeWCHaroen",
        "Narut Prasitlumkum",
        "Sittinop TiTiCHoaTraTTana",
        "Chutikarn Wittayalikit",
        "Angkawipa Trongtorsak",
        "Chanavuth Kanitsoraphan",
        "Prapaipan Putthapiban",
        "Kittika Poonsombudlert",
        "Pattara raTTanaWong",
        "eugene H. CHUng"
    ],
    "citedby-count": 0,
    "ref-count": 52,
    "ref-list": [
        "Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (vTaCH): a multicentre randomised controlled trial",
        "recurrent sustained ventricular tachycardia. 4. Pleomorphism",
        "Sequential endocardial resection for the surgical treatment of refractory ventricular tachycardia",
        "Morphologically distinct sustained ventricular tachycardias in coronary artery disease: significance and surgical results",
        "Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol implantable Cardioverter-Defibrillator Study Group",
        "incidence and determinants of multiple morphologically distinct sustained ventricular tachycardias",
        "Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial",
        "Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II",
        "Multicenter Automatic Defibrillator Implantation Trial-ii (MadiT-ii) research group. long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator",
        "improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia",
        "Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government",
        "Quality of life in the Canadian Implantable Defibrillator Study (CidS)",
        "randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac arrest Study Hamburg (CaSH)",
        "Prophylactic catheter ablation for the prevention of defibrillator therapy",
        "incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator",
        "ventricular Tachycardia ablation versus escalation of antiarrhythmic drugs",
        "Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli",
        "The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia",
        "Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? a meta-analysis of twenty-four observational studies",
        "Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses",
        "The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials",
        "ventricular Tachycardia in ischemic Heart disease",
        "Management of ventricular tachycardia in the ablation era: results of the european Heart rhythm association Survey",
        "Catheter ablation of Post-infarct vT: Mechanisms, Strategies and outcomes",
        "Meta-analysis in clinical trials",
        "Measuring inconsistency in meta-analyses",
        "Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis",
        "Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation",
        "Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia",
        "impact of new Technologies and approaches for Post-Myocardial infarction ventricular Tachycardia ablation during long-Term Follow-Up",
        "noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia",
        "reassessing noninducibility as ablation endpoint of post-infarction ventricular tachycardia: the impact of left ventricular function",
        "late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery",
        "Beyond the Storm: Comparison of Clinical Factors, arrhythmogenic Substrate, and Catheter ablation outcomes in Structural Heart disease Patients With versus Those Without a History of ventricular Tachycardia Storm",
        "Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy",
        "endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease",
        "outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of leipzig vT (HelP-vT) Study",
        "ablation of Stable vTs versus Substrate ablation in ischemic Cardiomyopathy: The viSTa randomized Multicenter Trial",
        "Scar extension Measured by Magnetic resonance-Based Signal intensity Mapping Predicts ventricular Tachycardia recurrence after Substrate ablation in Patients With Previous Myocardial infarction",
        "Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction",
        "Cardiac magnetic resonance-aided scar dechanneling: influence on acute and long-term outcomes",
        "long-term outcome of catheter ablation in post-infarction recurrent ventricular tachycardia",
        "Conquest of ventricular Tachycardia: insights into Mechanisms, innovations in Management: Contribution of Mark e. Josephson, Md, to Clinical electrophysiology",
        "vT ablation in the real-world: inducibility matters",
        "Myocardial Scar But not ischemia is associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With reduced left ventricular ejection Fraction",
        "impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death",
        "impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction, and preserved left ventricular ejection fraction",
        "Stunning, hibernation, and assessment of myocardial viability",
        "The relationship between left ventricular ejection fraction and infarct size assessed by Mri",
        "european Heart rhythm association (eHra); registered Branch of the european Society of Cardiology (eSC); Heart rhythm Society (HrS); american College of Cardiology (aCC); american Heart association (aHa). eHra/HrS expert Consensus on Catheter ablation of ventricular arrhythmias: developed in a partnership with the european Heart rhythm association (eHra), a registered Branch of the european Society of Cardiology (eSC), and the Heart rhythm Society (HrS); in collabora-",
        "noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ann Arbor",
            "@id": "60033182",
            "affilname": "University of Michigan Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033182",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60027795",
            "affilname": "Albert Einstein Healthcare Network",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027795",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Scottsdale",
            "@id": "60026952",
            "affilname": "Mayo Clinic Scottsdale-Phoenix, Arizona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026952",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Honolulu",
            "@id": "60013791",
            "affilname": "University of Hawai\u02bbi at M\u0101noa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013791",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}